Package 16571-226-50

{"route": ["ORAL"], "spl_id": "e4b713f1-a833-4fc7-8a0f-696077ddc280", "openfda": {"nui": ["N0000008486"], "upc": ["0316571226016"], "unii": ["6CW7F3G59X"], "rxcui": ["310433"], "spl_set_id": ["8215da86-d7af-4980-b6d6-4bd46f6bfeaf"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (16571-226-01)", "package_ndc": "16571-226-01", "marketing_start_date": "20240404"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (16571-226-50)", "package_ndc": "16571-226-50", "marketing_start_date": "20240404"}], "brand_name": "Gabapentin", "product_id": "16571-226_e4b713f1-a833-4fc7-8a0f-696077ddc280", "dosage_form": "TABLET", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "16571-226", "generic_name": "Gabapentin", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "600 mg/1"}], "application_number": "ANDA217995", "marketing_category": "ANDA", "marketing_start_date": "20240404", "listing_expiration_date": "20261231"}